Michelle Madrigal got candid about the “emotional rollercoaster” she has been experiencing as she tries to get pregnant while dealing with Hashimoto’s disease and endometriosis.. The ...

Madrigal Pharmaceuticals said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of its Rezdiffra treatment for adults with the liver disease ...

Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the best biotech stocks to invest in now. On June 20, Madrigal Pharmaceuticals moved closer to introducing the first treatment for metabolic ...

Michelle Madrigal got candid about the "emotional rollercoaster" she has been experiencing as she tries to get pregnant while dealing with Hashimoto’s disease and endometriosis. The ...

Madrigal's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved ...

Madrigal specifically discusses these risks and uncertainties in greater detail in the sections appearing in Part I, Item 1A of its Annual Report on Form 10-K for the year ended December 31, 2024 ...

Madrigal Pharmaceuticals, Inc. announced its participation in the 46th Annual Global Goldman Sachs Health Care Conference scheduled for June 11, 2025, at 10:40 A.M. EDT, where the company's ...

In May, Madrigal Pharmaceuticals announced two-year results from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial of Rezdiffra.

The European Union's drug regulator on Friday recommended conditional authorisation of Madrigal Pharmaceuticals' Rezdiffra, paving the way for it to become the first available treatment in the ...

Ahead, test your knowledge of some modern childhood classics and see how you stack up against your mini cinephile. We came up ...

Madrigal Pharma could be just weeks away from becoming the first drugmaker to claim EU approval for a treatment for metabolic dysfunction-associated steatohepatitis (MASH). The EMA's human ...

In light of this, Madrigal prioritizes staying in Spain, despite having offers from the MSL and Russia. We will see if he can stay in La Liga or move to the Second Division.